Approves

FDA approves second Alzheimer’s drug that may slow onset of disease | Alzheimer’s

by

Federal health authorities gave approval Tuesday to an experimental new drug that has been shown to delay the onset of Alzheimer’s disease in trials. Donanemab, made by Eli Lilly, is the second drug to win Food and Drug Administration (FDA) approval to treat patients showing early symptoms of the disease, most notably cognitive impairment. Last … Read more

FDA approves Alzheimer’s drug donanemab after months of delay

by

The Food and Drug Administration gave approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits of modestly slowing the progression of the devastating disease outweigh its risks, drugmaker Eli Lilly announced. The agency, in a surprise move in March, had delayed approval of the drug to further review its safety and effectiveness. … Read more

FDA Approves Eli Lilly’s Alzheimer’s Drug That Slows Memory Decline

by

The Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking skills in people with the disease, the drugmaker said Tuesday. The drug donanemab, which will be sold under the brand name Kisunla, is an infusion of … Read more